MedPath

Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes

Conditions
CKD, Home Dialysis, Peritoneal Dialysis, Home Haemodialysis, PROMs, Quality of Life, Cost-effectiveness, ESRD, RenalReplacement Therapy.<br />nierfalen, chronische nierschade, thuisdialyse, peritoneale dialyse, thuishaemodialyse, kwaliteit van leven, kosteneffectiviteit, nierfunctievervangende therapie.
Registration Number
NL-OMON23350
Lead Sponsor
VU University Medical Center Amsterdam (VUmc)<br>University Medical Center Utrecht (UMCU)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
1600
Inclusion Criteria

Age > 18 years

- indication to start with RRT

Exclusion Criteria

- unwillingness to provide informed consent

- life expectancy < 3 months

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life, obtained from the following questionnaires: SF-12, Dialysis Symptom Index and EQ5D-5L<br><br>
Secondary Outcome Measures
NameTimeMethod
clinical outcomes (phosphate and anaemia control, nutritional status, infectious complications, hospitalisation, mortality) and cost-effectiveness.
© Copyright 2025. All Rights Reserved by MedPath